Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ripple-Mapping for the Detection of Long Duration Action Potential Areas in Patients With Brugada Syndrome

NCT03435393 is registered in ClinicalTrials.gov with University College London Hospitals as lead sponsor.

NCT NCT03435393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03435393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ripple-Mapping for the Detection of Long Duration Action Potential Areas in Patients With Brugada Syndrome
Lead sponsor
University College London Hospitals
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2017
Completion date
September 30, 2020
Enrollment
10 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brugada syndrome